Every Form 4 that The Charles Schwab Corporation (SCHW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SCHW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SCHW filings page.
Charles A. Ruffel, a director of SCHW, received 1,222 nonqualified stock options on October 1, 2026, in lieu of cash compensation otherwise payable as director fees. The options vested immediately, have an exercise price of $98.37 per share and were reported as a directly held position of 1,222 options after the award.
Charles Schwab Corp. (SCHW) director Frank C. Herringer acquired 445 restricted stock units on October 1, 2026, in lieu of cash compensation otherwise payable as director fees. Each RSU represents a right to receive one share of company stock. The RSUs are held in a rabbi trust for his benefit and are distributed when he leaves the Board of Directors. His reported resulting position was 153,636.78 RSUs, including 440.52 RSUs acquired through dividend reinvestment.
Charles Schwab Corporation (SCHW) director Stephen A. Ellis acquired 369 restricted stock units on October 1, 2026, in lieu of cash compensation otherwise payable as director fees. The units were received under the Directors’ Deferred Compensation Plan II and are held in a rabbi trust for Ellis’s benefit, with distribution when he leaves the Board. His resulting position was 13,683.75 RSUs, including 38.29 acquired through dividend reinvestment.
Charles Schwab Corp. (SCHW) director Marianne Catherine Brown acquired 407 restricted stock units on October 1, 2026, in lieu of cash compensation otherwise payable as director fees. Each unit represents a right to receive one share of company stock. The units were received under Directors' Deferred Compensation Plan II, are held in a rabbi trust for her benefit, and are distributed when she leaves the Board. Her reported position following the award was 8,700.21 RSUs, including 23.85 RSUs acquired through dividend reinvestment.
SCHW officer Neesha Hathi, MD, Head Wealth Adv, Bnk, Tst, exercised 5,000 nonqualified stock options at an exercise price of $41.98 per share on October 1, 2026. The shares received were contributed to a trust, which sold 5,000 shares that day at a weighted average price of $97.8014 per share under a Rule 10b5-1 trading plan adopted by Hathi on May 29, 2026. After the exercise, 13,950 options remained; the trust held 5,770 shares after the sale.
Stephen A. Ellis, a director of SCHWAB CHARLES CORP (SCHW), exercised 1,918 nonqualified stock options on September 23, 2026, at a $31.48 exercise price, acquiring 1,918 common shares. The options were received under the Directors' Deferred Compensation Plan II and vested immediately; the shares received upon exercise were contributed to a trust. Reported positions after the transactions were 7,445 common shares held directly and 104,210.453 shares held indirectly by trust, including 299.7567 shares acquired through dividend reinvestment. No Rule 10b5-1 plan is reported.
SCHWAB CHARLES CORP (SCHW) executive Neesha Hathi, MD and Head of Wealth Advisory, Banking and Trust, exercised a nonqualified stock option for 3,177 shares of common stock at an exercise price of $52.05 per share on September 1, 2026. The shares received were contributed to a trust, which then sold 3,177 shares at a weighted average price of $109.04 per share pursuant to a Rule 10b5-1 trading plan, leaving 5,770 shares of SCHW common stock held indirectly by the trust.
SCHWAB CHARLES CORP (SCHW) reported that Co-Chairman Walter W. Bettinger II exercised a nonqualified stock option for 74,388 shares of common stock at an exercise price of $46.81 per share, originally granted under the 2013 Stock Incentive Plan. The same number of shares was acquired indirectly by a family trust and then sold by that trust in multiple trades totaling 74,388 shares at a weighted average price of $110.9137 per share. Following the option exercise, 154,589 option shares remain directly held, and indirect holdings include shares held through an ESOP, ESPP and by the reporting person's spouse and related accounts.
SCHWAB CHARLES CORP (SCHW) reported that officer Neesha Hathi, MD, Head Wealth Adv, Bnk, Tst, exercised a nonqualified stock option for 3,177 shares of common stock at an exercise price of $52.05 per share, originally granted under the company’s 2013 Stock Incentive Plan. The acquired shares were contributed to a trust and, on the same date, that trust sold 3,177 shares of common stock at a weighted average price of $108.1201 per share in multiple trades between $107.805 and $108.725. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.
SCHWAB CHARLES CORP (SCHW) reported an insider ownership change by Co-Chairman Charles R. Schwab. On 2026-08-27, an entity described as a trust made a bona fide gift transfer of 9,300 shares of Common Stock, reported as an indirect disposition. Following this gift, the trust holds 53,549,441 shares indirectly. Additional reported indirect holdings are 30,021,463 shares held by a limited partnership, 44,025 shares held by 188 Corp, and 10,624,797.33 shares held by the spouse as trustee.
SCHWAB CHARLES CORP (SCHW) director Carolyn Schwab-Pomerantz reported an indirect sale of 9,175 common shares on August 26, 2026, at a weighted average price of $109.2531 per share by a trust. After this sale, that trust holds 1,323,161.6599 shares, alongside additional reported direct and other indirect holdings.
SCHWAB CHARLES CORP (SCHW) director and Co-Chairman Charles R. Schwab reported an indirect sale of common stock on August 24, 2026. An affiliated trust sold 117,000 shares at a weighted average price of $113.2001 per share, with individual trades ranging from $112.77 to $113.65. Following this transaction, the trust held 53,558,741 shares indirectly. Additional indirect holdings reported as of that date include 30,021,463 shares held by a limited partnership, 44,025 shares held by 188 Corp, and 10,624,797.33 shares held by Mr. Schwab's spouse as trustee.
SCHWAB CHARLES CORP (SCHW) Co-Chairman and director Walter W. Bettinger reported an option exercise and related share sale. He exercised 176,210 nonqualified stock options at an exercise price of $46.81 per share, receiving an equal number of common shares indirectly through a family trust. The family trust then sold 176,210 common shares at a weighted-average price of $113.486 per share in multiple trades. Following the option exercise, 228,977 options remain directly held. Additional indirect holdings include 6,728.899 shares held by an ESOP, 4,334 by an ESPP, 2,403.0846 by a spouse, and 176.1192 by a spouse as trustee.
For SCHWAB CHARLES CORP (SCHW), director and Co-Chairman Charles R. Schwab reported two bona fide gifts of common stock held indirectly through a trust: 54,550 shares on August 18, 2026 and 45,500 shares on August 17, 2026, with no sale proceeds reported. The filing also lists indirect holdings after these events of 30,021,463 shares by a limited partnership, 44,025 shares by 188 Corp, and 10,624,797.33 shares held by his spouse as trustee.
SCHWAB CHARLES CORP (SCHW) insider Jonathan S. Beatty, MD, Head of Advisor Services, reported selling 1,000 shares of common stock on 2026-08-17 at a weighted average price of $111.3301 per share, through a trust. The trust now holds 10,738 shares, and Beatty also reports 32,459 shares held directly.
The sale price reflects multiple trades executed between $111.19 and $111.405 per share in open market or private transactions, with the weighted average disclosed.
SCHWAB CHARLES CORP executive Jonathan M. Craig, MD and Head of Retail Investing, exercised a nonqualified stock option for 21,866 shares of common stock at an exercise price of $46.81 per share on August 14, 2026. The shares received upon exercise were contributed to a revocable trust, after which the same 21,866 shares were sold indirectly by the trust at a weighted average price of $111.0257 per share under a Rule 10b5-1 trading plan adopted on November 11, 2025. The option, granted under the company’s 2013 Stock Incentive Plan, had an original expiration date of March 1, 2029.
SCHWAB CHARLES CORP (SCHW) executive Dennis Howard, MD and Chief Technology, Operations & Data Officer, reported a sale of 2,198 shares of Common Stock on 2026-08-13 at $110.00 per share. The transaction was executed under a Rule 10b5-l trading plan adopted on November 25, 2025, and left him with 6,980 directly held shares.
Charles R. Schwab, Co-Chairman of Schwab Charles Corp, reported an indirect open-market sale of 46,410 shares of common stock on 2026-08-12 at a weighted average price of $108.176 per share, executed in multiple trades between $108.02 and $108.35. After this transaction, an affiliated limited partnership held 30,021,463 shares, and additional indirect holdings reported include 53,775,791 shares by a trust, 44,025 shares by 188 Corp, and 10,624,797.33 shares by the spouse as trustee.
Schwab Charles R., Co-Chairman of SCHWAB CHARLES CORP, reported an open-market sale of 46,445 shares of common stock on 2026-08-11 at a weighted average price of about $107.78 per share, executed through a limited partnership. After this sale, that limited partnership held 30,067,873 shares indirectly. The filing also lists additional indirect common stock holdings of 53,775,791 shares held by a trust, 44,025 shares held by 188 Corp, and 10,624,797.33 shares held by the reporting person’s spouse as trustee.
Schwab Charles R., Co-Chairman of SCHWAB CHARLES CORP, reported a bona fide gift transfer of 37,200 shares of common stock on 2026-08-06, made through an entity reported as held indirectly by Trust. A footnote states this change reflects his resignation as trustee of two trusts established for the benefit of his relatives.
Following this activity, the filing lists indirect holdings of 53,775,791 shares by Trust, 30,114,318 shares by a Limited Partnership, 44,025 shares by 188 Corp, and 10,624,797.33 shares by his spouse as trustee.
Charles Schwab Corporation’s Chief Risk Officer, Nigel J. Murtagh, exercised nonqualified stock options for a total of 26,675 shares of Common Stock at an exercise price of $46.81 per share, and sold the same number of shares at weighted average prices of about $109 per share on August 6 and 10, 2026. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on November 25, 2025. He also reports an indirect holding of 2,621 shares of Common Stock through an ESPP.
Schwab Charles Corp director Paula A. Sneed reported an indirect sale of 5,263 shares of common stock on 2026-08-07 at a weighted average price of $107.1545 per share, executed by a trust. After this transaction, the trust held 91,711.1605 shares, and Sneed also reported 9,675 shares held directly. The sale price reflects multiple trades between $107.07 and $107.205 per share.
A trust associated with Charles Schwab Corp director Carolyn Schwab-Pomerantz reported a sale of 18,561 shares of common stock on 2026-08-05. The shares were sold at a weighted average price of $107.6998 per share, with individual trade prices ranging from $107.53 to $107.87. Following this transaction, the trust holds 1,332,336.6599 shares indirectly. Separate entries report 11,226 shares held directly, 436,149 shares held indirectly by a spouse as trustee, and 2,798 shares held indirectly by an LLC.
Schwab Charles Corp executive Jonathan M. Craig, MD, Head of Retail Investing, exercised 21,750 nonqualified stock options at $46.81 per share, receiving the same number of common shares. These shares were contributed to a revocable trust, which sold 21,750 shares at a weighted average $107.0231 under a Rule 10b5-1 trading plan adopted on November 11, 2025. Craig continues to hold 21,866 stock options expiring March 1, 2029.
Schwab Charles Corp director Carolyn Schwab-Pomerantz reported selling 22,640 shares of common stock on August 4, 2026, at a weighted average price of $106.362 per share, executed in multiple trades between $106.22 and $106.46.
After the sale, an affiliated trust held 1,350,897.6599 shares indirectly. She also reported 11,226 shares held directly, 436,149 shares held indirectly by her spouse as trustee, and 2,798 shares held indirectly through an LLC.
SCHWAB CHARLES CORP executive Howard Dennis, MD, Chief Tech, OPS & Data Officer, reported a tax-withholding disposition of 1,292 shares of common stock on August 1, 2026. Shares were withheld to cover taxes upon settlement of restricted stock units at $104.8675 per share, leaving 9,178 shares held directly.
Charles R. Schwab, Co-Chairman of Schwab Charles Corp, reported indirect sales of 95,250 and 47,650 shares of common stock on August 3–4, 2026 through a trust, at weighted average prices of $105.5162 and $106.0770 over multiple trade prices. The filing also reports indirect holdings of 30,114,318 shares by a limited partnership, 44,025 shares by 188 Corp, and 10,624,797.33 shares held by his spouse as trustee.
Charles R. Schwab, Co‑Chairman of Schwab Charles Corp, reported indirect open‑market sales totaling 143,450 shares of common stock on July 28–29, 2026, at weighted‑average prices of $105.5964 and $105.8152 per share, plus a 60,000‑share bona fide gift from a trust.
After these transactions, interests reported as indirectly held include 30,114,318 shares through a limited partnership, 44,025 shares through 188 Corp, and 10,624,797.33 shares through a trust for which his spouse serves as trustee.
Charles Schwab director Carolyn Schwab-Pomerantz reported two indirect transactions in the company’s common stock on July 28, 2026. A trust associated with her sold 22,650 shares at a weighted average price of $105.713 per share, executed in multiple trades between $105.60 and $105.82. The same trust made a bona fide gift of 271 shares. Following these transactions, she reports 11,226 shares held directly, and indirect holdings of 436,149 shares by a spouse acting as trustee and 2,798 shares held by an LLC.
Dennis Howard, MD and Chief Technology, Operations & Data Officer of Schwab Charles Corp, exercised nonqualified stock options for 28,000 shares of common stock at an exercise price of $64.10 per share on July 28, 2026. He received 28,000 shares of common stock and on the same date sold 28,000 shares at a weighted average price of $105.0094 per share in multiple trades between $105.00 and $105.025, pursuant to a Rule 10b5-1 trading plan adopted on November 25, 2025.
Following the option exercise, 56,000 option shares remained outstanding from this grant, which was issued under the company’s 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.
Schwab Charles Corp Co-Chairman Walter W. Bettinger exercised 285896 nonqualified stock options at $52.0500 per share on July 27–28, 2026, converting them into an equal number of common shares held indirectly by a family trust. These options were granted under the company’s 2013 Stock Incentive Plan and carry an expiration date of March 1, 2028.
The family trust then sold 285896 Schwab common shares in open-market transactions, with prices reported as weighted averages and the underlying trades executed in ranges between $103.51 and $105.625 per share. Bettinger also reports indirect holdings through an ESOP, an ESPP and spouse-related accounts.
Nigel J. Murtagh, Chief Risk Officer of Charles Schwab, exercised 32,947 nonqualified stock options into common stock at $46.81 per share on July 27, 2026, under the company’s 2013 Stock Incentive Plan. He then sold 21,947 shares at a weighted-average price of $104.00 and 11,000 shares at a weighted-average price of $104.0317 in open-market transactions pursuant to a Rule 10b5-1 trading plan adopted on November 25, 2025.
After these transactions, he reports 15,675 options remaining from this grant and indirect ownership of 2,621 shares through an employee stock purchase plan.
Charles R. Schwab, Co-Chairman of Schwab Charles Corp, reported an indirect sale of 45,500 shares of common stock on July 24, 2026 at $101.7185 per share by a trust. Following this transaction, the trust held 54,128,841 shares indirectly, alongside additional indirect holdings through a limited partnership, 188 Corp, and his spouse as trustee.
Schwab General Counsel Peter J. Morgan III sold 6,952 shares of common stock on July 23, 2026 at a weighted average price of $102.0341 per share, with individual trades between $101.98 and $102.09. After this open-market or private sale, he reported 0 directly held shares and indirect plan holdings of 152.136 shares through an ESOP (based on a June 30, 2026 plan statement) and 697 shares through an ESPP (based on a July 15, 2026 plan statement).
Charles Schwab Chief Risk Officer Nigel J. Murtagh exercised nonqualified stock options for 4,053 shares of common stock at $46.81 per share and on July 21, 2026 sold 4,053 shares at a $104.1374 weighted average price under a Rule 10b5-1 trading plan, retaining 48,622 options and 2,621 shares indirectly through an ESPP.
Jonathan S. Beatty, MD and Head of Advisor Services at Schwab Charles Corp, reported the sale of 2,000 shares of common stock held indirectly through a trust on July 21, 2026 at a $104.2055 weighted average price, pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2026.
After this transaction, the trust holds 11,738 shares, while Beatty also reports 32,459 shares held directly. The sale was executed in multiple trades at prices between $104.12 and $104.405 per share.
Charles Schwab Corporation executive Jonathan M. Craig, MD and Head of Retail Investing, exercised nonqualified stock options for 21,750 shares of common stock at $46.81 per share and contributed the shares to a revocable trust. On the same July 7, 2026 date, the trust executed an open-market sale of 21,750 shares at a weighted-average price of $102.0102 per share under a pre-arranged Rule 10b5-1 trading plan. Following the option exercise, 43,616 options remain outstanding and will expire on March 1, 2029.
Schwab Charles Corp executive Jonathan S. Beatty, MD and Head of Advisor Services, reported an open-market sale of 2,000 shares of Common Stock at a weighted average price of $102.0089 through a trust. The sale was made under a pre-arranged Rule 10b5-1 trading plan. After the transaction, the trust holds 13,738 shares, and Beatty also holds 32,459 shares directly, indicating he retains a sizable position.
Ellis Stephen A reported acquisition or exercise transactions in this Form 4 filing.
Schwab Charles Corp director Stephen A. Ellis received a grant of 379 restricted stock units on July 1, 2026. Each RSU represents the right to receive one share of company common stock. The units were granted under the Directors' Deferred Compensation Plan II in lieu of cash director fees and are held in a rabbi trust for his benefit.
The RSUs will be distributed to him when he leaves the Board of Directors. Following this award and prior accruals, Ellis holds a total of 13,276.46 RSUs, including 45.48 units accumulated through dividend reinvestment.
HERRINGER FRANK C reported acquisition or exercise transactions in this Form 4 filing.
Schwab Charles Corp director Frank C. Herringer received a grant of 457 restricted stock units (RSUs) linked to the company’s common stock. These RSUs were awarded as director compensation in lieu of cash fees under the Directors' Deferred Compensation Plan II.
The RSUs are held in a rabbi trust for his benefit and will be distributed when he leaves the Board of Directors. Following this award, his directly held RSU balance is 152,751.26 units, including 537.02 RSUs that were accumulated through dividend reinvestment. The filing reflects compensation, not an open-market stock purchase or sale.
Schwab Charles Corp director Charles A. Ruffel received a grant of nonqualified stock options covering 1,280 shares of common stock. The options have an exercise price of $95.78 per share, vested immediately, and expire on July 1, 2036. According to the disclosure, the options were issued under the Directors' Deferred Compensation Plan II in lieu of cash director fees, leaving Ruffel with 1,280 options following this transaction.
Brown Marianne Catherine reported acquisition or exercise transactions in this Form 4 filing.
Schwab Charles Corp director Marianne Catherine Brown received a grant of 418 restricted stock units (RSUs) tied to company common stock. Each RSU represents the right to receive one share of stock. After this award, she holds a total of 8,269.36 RSUs.
The RSUs were granted under the Directors' Deferred Compensation Plan II and are held in a rabbi trust for her benefit. They were received in lieu of cash director fees and will be distributed when she leaves the Board, making this a non-cash, compensation-related award rather than an open-market stock purchase or sale.
Schwab executive Jonathan S. Beatty reported recent stock transactions involving Charles Schwab common stock. A trust associated with him sold 2,000 shares on July 2, 2026 at an average price of $97.0297 and another 2,000 shares on July 6, 2026 at $100.0074, leaving the trust holding 15,738 shares.
Separately, 1,036 directly held shares were withheld on July 1, 2026 to cover taxes upon settlement of restricted stock units granted on July 1, 2024, and this was not an open-market sale. After this tax-withholding disposition, he directly held 32,459 shares. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 27, 2026.
Schwab director Stephen A. Ellis reported routine equity compensation activity and related trust movements. He exercised a nonqualified stock option to acquire 2,258 shares of Common Stock at $25.11 per share, a derivative exercise rather than an open-market purchase.
Following the exercise, Ellis held 7,445 Common Stock shares directly. A separate entry shows 101,992.6963 Common Stock shares held indirectly by a trust, with footnotes explaining that shares received on exercise and other directly held shares were contributed or transferred to the trust.
Charles Schwab CFO Michael D. Verdeschi reported a routine tax-related share disposition. On settlement of previously granted restricted stock units, 6,519 shares of common stock were withheld to cover tax obligations at a price of $87.42 per share. These shares were not sold in the open market but used to pay taxes due on equity compensation. After this withholding, Verdeschi directly holds 47,442 shares of Charles Schwab common stock.
Schwab Charles Corp director John K. Adams Jr. received equity compensation on May 26, 2026. He was granted 1,602 shares of Common Stock in the form of restricted stock units and 3,977 nonqualified stock options with an exercise price of $89.40 per share.
Both the restricted stock units and options were granted under the company’s 2022 Stock Incentive Plan and vest 25% on the first and second anniversaries of the grant date and 50% on the third anniversary. Following the stock grant, Adams directly holds 50,711.239 shares of Common Stock, including 304.2606 shares acquired through dividend reinvestment.
Charles Schwab Corporation director Charles A. Ruffel reported equity compensation awards rather than open-market trades. He received a grant of restricted stock units representing 1,602 shares of Common Stock at a stated price of $0.00 per share.
The RSUs were granted under the company’s 2022 Stock Incentive Plan and vest 25% on each of the first and second anniversaries of the grant date and 50% on the third anniversary. Following this award, his direct Common Stock holdings reported in this entry total 11,380.6867 shares.
Ruffel was also granted a Nonqualified Stock Option covering 3,977 shares of Common Stock at an exercise price of $89.40 per share, expiring on May 26, 2036, with the same 25/25/50 vesting schedule. Indirect holdings include 3,527.8656 shares held by a 401(k) account and 9,756.7612 shares held by an IRA, which incorporate shares acquired through dividend reinvestment.
Schwab-Pomerantz Carolyn reported acquisition or exercise transactions in this Form 4 filing.
SCHWAB CHARLES CORP director Carolyn Schwab-Pomerantz reported new equity awards and updated holdings. She received a grant of 1,602 shares of common stock as restricted stock units and 3,977 nonqualified stock options with a strike price of $89.40 per share.
Both the RSUs and options were granted under the company’s 2022 Stock Incentive Plan and vest 25% on the first and second anniversaries of the grant date and 50% on the third. Following the awards, she holds 11,226 common shares directly, plus indirect holdings of common stock through an LLC, a trust, and a trust where her spouse is trustee.
Schwab director Joan Dea received new equity compensation awards. She was granted 1,602 shares of common stock in the form of restricted stock units and 3,977 nonqualified stock options with an exercise price of $89.40 per share. Following these awards, she directly holds 28,440 common shares and 3,977 options. Both the RSUs and options were granted under the company’s 2022 Stock Incentive Plan and vest 25% on the first and second anniversaries of the grant date and 50% on the third anniversary.
Schwab Charles Corp President & CEO Richard A. Wurster purchased 21,959 shares of common stock in an open-market transaction. The shares were bought on May 28, 2026 at a weighted average price of $84.2257 per share.
Following this purchase, Wurster directly holds 218,409 common shares. A separate entry shows indirect ownership of 4,595 shares held by ESPP, reflecting shares acquired through an employee stock purchase arrangement. The filing notes the buy was executed in multiple trades between $84.04 and $84.51 per share.